Articles about AstraZeneca

Kim orders tougher virus steps after North Korea shuns vaccines

03 Sep 2021

Kim orders tougher virus steps after North Korea shuns vaccines

North Korean leader Kim Jong Un ordered officials to wage a tougher epidemic prevention campaign after he turned down some foreign COVID-19 vaccines offered via the UN-backed immunization program.

Pfizer, AstraZeneca vaccines less effective against Delta variant: Oxford study

19 Aug 2021

Pfizer, AstraZeneca vaccines less effective against Delta variant: Oxford study

COVID-19 vaccines developed by Pfizer and AstraZeneca are less effective against the Delta variant of the coronavirus, compared to the Alpha variant, a study led by researchers at the University of Oxford said.

COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll

05 Aug 2021

COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll

Mattel, the maker of the Barbie doll, has created a doll to honor Professor Sarah Gilbert, who led the development of the Oxford University and AstraZeneca COVID-19 vaccine.

India mulls mixing Covishield, Sputnik doses; no recommendation yet

04 Aug 2021

India mulls mixing Covishield, Sputnik doses; no recommendation yet

India is considering allowing the mixing of different COVID-19 vaccine doses in what could be the first mix-and-match inoculation.

France allows visitors vaccinated with Indian-made AstraZeneca vaccine

17 Jul 2021

France allows visitors vaccinated with Indian-made AstraZeneca vaccine

France will now allow international travelers who have received AstraZeneca's Indian-manufactured vaccine into the country starting Sunday.

Mix-and-match COVID-19 vaccines: What do studies say?

02 Jul 2021

Mix-and-match COVID-19 vaccines: What do studies say?

In most coronavirus vaccination regimes, two doses of the same brand are given a few weeks apart.

Single dose of Pfizer, AstraZeneca vaccines offers 60 percent protection

24 Jun 2021

Single dose of Pfizer, AstraZeneca vaccines offers 60 percent protection

A single dose of Pfizer or AstraZeneca COVID-19 vaccine offers around 60 percent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.

Efforts on to restart AstraZeneca shipments from India: WHO official

19 Jun 2021

Efforts on to restart AstraZeneca shipments from India: WHO official

The WHO is urgently trying to work with AstraZeneca, Serum Institute of India (SII) as well as the Indian government to restart shipments of COVID-19 vaccines to countries, a senior official at the UN health agency said.

Pfizer, AstraZeneca vaccines protect against Delta variant, says study

15 Jun 2021

Pfizer, AstraZeneca vaccines protect against Delta variant, says study

Pfizer and AstraZeneca vaccines provide good protection against the Delta variant of coronavirus, first identified in India, says a study published in The Lancet Journal.

AstraZeneca vaccine linked to small risk of low blood platelets

10 Jun 2021

AstraZeneca vaccine linked to small risk of low blood platelets

The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a small risk of developing a blood condition characterized by low platelet counts, according to a UK study.

Two doses of AstraZeneca vaccine 85%-90% effective, real-world data shows

21 May 2021

Two doses of AstraZeneca vaccine 85%-90% effective, real-world data shows

Two doses of the Oxford/AstraZeneca COVID-19 vaccine are around 85 percent to 90 percent effective against the symptomatic disease, Public Health England (PHE) has said, citing a new analysis of real-world data from the roll-out of the shot in the UK.

AstraZeneca vaccine's single dose reduces death risk by 80%: Data

11 May 2021

AstraZeneca vaccine's single dose reduces death risk by 80%: Data

A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.

COVID-19 vaccine formulas shouldn't be shared with India: Bill Gates

02 May 2021

COVID-19 vaccine formulas shouldn't be shared with India: Bill Gates

It's a terrible time to be a publicist for Bill Gates. The billionaire, who the mainstream media celebrates as a philanthropist, is being criticized for his stance on vaccine patents.

Denmark becomes first European country to permanently drop AstraZeneca vaccine

15 Apr 2021

Denmark becomes first European country to permanently drop AstraZeneca vaccine

Even as vaccines became the world's biggest hope against the highly contagious coronavirus, Denmark has stopped using the one made by British-Swedish pharma giant AstraZeneca.

AstraZeneca serves legal notice to Serum Institute over vaccine delays

08 Apr 2021

AstraZeneca serves legal notice to Serum Institute over vaccine delays

Serum Institute of India (SII), the manufacturer of the coronavirus vaccine Covishield, has been served a legal notice by the drug maker AstraZeneca over delays in vaccine supply, the company's CEO Adar Poonawalla confirmed in an interview earlier this week.

UK: Seven blood-clotting-related deaths in 18mn AstraZeneca COVID-19 vaccine recipients

03 Apr 2021

UK: Seven blood-clotting-related deaths in 18mn AstraZeneca COVID-19 vaccine recipients

On Saturday, the United Kingdom's medical regulator said that seven people—out of more than 18 million recipients of the Oxford-AstraZeneca jab for COVID-19 in the country—died of unusual blood clots.

Facing delay in securing vaccines, Lanka temporarily suspends COVID-19 jabs

02 Apr 2021

Facing delay in securing vaccines, Lanka temporarily suspends COVID-19 jabs

Sri Lanka has temporarily halted its COVID-19 vaccination program as there was a delay in securing more AstraZeneca vaccines from the Serum Institute of India (SII), a top health minister has said.

Germany halts AstraZeneca vaccine use for under-60s over clot fears

31 Mar 2021

Germany halts AstraZeneca vaccine use for under-60s over clot fears

Germany will allow general use of the AstraZeneca coronavirus vaccine only for people aged above 60 years, imposing restrictions on younger people taking the jab after several severe cases of blood clots were reported, the German government said on Tuesday.

Amid growing cases, India temporarily halts export of AstraZeneca's vaccine

25 Mar 2021

Amid growing cases, India temporarily halts export of AstraZeneca's vaccine

Facing a sudden spike in coronavirus cases, India has halted the export of the AstraZeneca vaccine for now, Reuters reported quoting two sources. Millions of doses of the vaccine are being manufactured by the Pune-based Serum Institute of India (SII), the world's biggest vaccine-maker.

AstraZeneca says US trial data shows vaccine 79% effective

22 Mar 2021

AstraZeneca says US trial data shows vaccine 79% effective

AstraZeneca says advanced trial data from a US study on its COVID-19 vaccine shows it is 79 percent effective.

AstraZeneca's coronavirus vaccine dubbed safe; European countries to resume vaccination

19 Mar 2021

AstraZeneca's coronavirus vaccine dubbed safe; European countries to resume vaccination

A chunk of European countries, that had earlier stopped using AstraZeneca's coronavirus vaccine over blood clot concerns, will resume the vaccination drive after the jab got the support of the continent's top medical regulator.

Why European countries are halting the AstraZeneca shot

16 Mar 2021

Why European countries are halting the AstraZeneca shot

The largest and most influential European countries, like Germany, France, and Italy, have paused the rollout of coronavirus vaccine, developed by the University of Oxford and British-Swedish pharma giant AstraZeneca over blood clot fears.

Looking at adverse effects: India on concerns over AstraZeneca vaccine

13 Mar 2021

Looking at adverse effects: India on concerns over AstraZeneca vaccine

India is constantly looking at all the adverse side effects as it conducts a massive coronavirus vaccination program, a top medical expert said today.

Use of AstraZeneca's coronavirus vaccine suspended in Denmark, Norway, Iceland

12 Mar 2021

Use of AstraZeneca's coronavirus vaccine suspended in Denmark, Norway, Iceland

Denmark, Norway, and Iceland have temporarily suspended the use of the coronavirus vaccine developed by British-Swedish pharma giant AstraZeneca as several patients developed blood clots after getting the jab.

AstraZeneca has sold its stake in Moderna for $1 billion

01 Mar 2021

AstraZeneca has sold its stake in Moderna for $1 billion

British pharmaceutical company AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc., the American pharmaceutical giant, for more than $1 billion, according to a report in The Times.

COVID-19 vaccines: SII to play huge role in mass production

25 Feb 2021

COVID-19 vaccines: SII to play huge role in mass production

British-Swedish pharmaceutical giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.

WHO authorizes AstraZeneca's COVID-19 vaccine for emergency use

16 Feb 2021

WHO authorizes AstraZeneca's COVID-19 vaccine for emergency use

The World Health Organization has granted an emergency authorization to AstraZeneca's coronavirus vaccine, a move that should allow the UN agency's partners to ship millions of doses to countries as part of a UN-backed program to tame the pandemic.

South Africa scraps AstraZeneca vaccine, will give J&J jabs

10 Feb 2021

South Africa scraps AstraZeneca vaccine, will give J&J jabs

South Africa will give the unapproved Johnson & Johnson vaccine to its frontline healthcare workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant in South Africa, Health Minister Zweli Mkhize announced on Wednesday.

UK begins world's first alternate dosing COVID-19 vaccine trial

04 Feb 2021

UK begins world's first alternate dosing COVID-19 vaccine trial

Health chiefs in the UK on Thursday began what they have described as the world's first clinical trial of patients who will receive different COVID-19 vaccines for their first or second dose, to detect its impact on immunity against coronavirus.

Oxford/AstraZeneca first jab cuts COVID-19 transmission substantially: UK study

03 Feb 2021

Oxford/AstraZeneca first jab cuts COVID-19 transmission substantially: UK study

According to a new Oxford University study, the first dose of the two-dose Oxford/AstraZeneca vaccine can cut coronavirus transmissions by around 67 percent and therefore, have a substantial effect on controlling the spread.

Russia's coronavirus vaccine approved for use in Mexico

03 Feb 2021

Russia's coronavirus vaccine approved for use in Mexico

Mexico approved the Russian coronavirus vaccine Sputnik V for use on Tuesday, just hours after the publication of early results of an advanced study saying it is about 91 percent effective.

South Africa welcomes first delivery of COVID-19 vaccines

02 Feb 2021

South Africa welcomes first delivery of COVID-19 vaccines

South Africa gave a hero's welcome on Monday to the delivery of its first COVID-19 vaccines - one million doses of the AstraZeneca vaccine produced by the Serum Institute of India.

Sri Lanka: No adverse reactions so far following vaccination

30 Jan 2021

Sri Lanka: No adverse reactions so far following vaccination

No adverse reactions or side-effects have so far been reported by those who were vaccinated in Sri Lanka on Friday with Oxford-AstraZeneca vaccine Covishield, provided by India, health officials said on Saturday.

Johnson & Johnson's one-shot COVID-19 vaccine shows 66% strong efficacy

29 Jan 2021

Johnson & Johnson's one-shot COVID-19 vaccine shows 66% strong efficacy

Johnson & Johnson's (J&J) much-awaited COVID-19 vaccine has reportedly exhibited strong protection against the virus.

Diplomats, including from Pakistan and China, offered coronavirus vaccines

26 Jan 2021

Diplomats, including from Pakistan and China, offered coronavirus vaccines

After starting its vaccination drive on January 16, New Delhi has offered made-in-India vaccines to diplomatic corps, including to those from Pakistan and China.

Top French advisor talks third lockdown as coronavirus cases surge

25 Jan 2021

Top French advisor talks third lockdown as coronavirus cases surge

France will have to enforce a third national lockdown to handle the worrying surge of coronavirus cases, the country's top medical advisor Prof Jean-Francois Delfraissy said on Sunday.

After SII fire, BCG, rotavirus vaccine production to be hit

22 Jan 2021

After SII fire, BCG, rotavirus vaccine production to be hit

Thursday's fire at Pune's Serum Institute of India will impact the production of BCG and rotavirus vaccines in the future, the company said on Friday.

Five killed in Serum Institute fire; Maharashtra government orders probe

21 Jan 2021

Five killed in Serum Institute fire; Maharashtra government orders probe

The Maharashtra government has ordered a probe into the fire that broke out at the Serum Institute of India in Pune on Thursday, killing at least five people.

Pune: Fire breaks out at Serum Institute of India

21 Jan 2021

Pune: Fire breaks out at Serum Institute of India

On Thursday afternoon, a fire broke out at the Terminal 1 gate of Serum Institute of India, Pune.

Coronavirus: PM Modi, CMs to get vaccinated in second phase

21 Jan 2021

Coronavirus: PM Modi, CMs to get vaccinated in second phase

Prime Minister Narendra Modi, 70, would be getting the coronavirus vaccine shot in the second phase of the drive launched last week, reports said on Thursday.